HHS Looking At Impact Of NDC Changes, Repackaging On Medicaid Rebates
Executive Summary
The HHS Inspector General is considering a study to support a legislative change to the Medicaid rebate program to ensure that New Drug Code changes cannot be used to circumvent inflation restraints for the Medicaid system.
You may also be interested in...
Medicaid To Seek Repayment Of Rebates On Drugs Sold To HMO Repackagers
The Health Care Financing Administration intends to follow an HHS Inspector General recommendation to require drug manufacturers who excluded sales to HMO repackagers from their Medicaid best price determinations to pay back the lost rebates.
Medicaid To Seek Repayment Of Rebates On Drugs Sold To HMO Repackagers
The Health Care Financing Administration intends to follow an HHS Inspector General recommendation to require drug manufacturers who excluded sales to HMO repackagers from their Medicaid best price determinations to pay back the lost rebates.
SmithKline, Bayer Subpoenaed In Medicaid Repackaging Investigation
A Boston grand jury is conducting an investigation of Kaiser's prescription drug repackaging operations as a potential avenue around the Medicaid "best price" rebate system.